Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of ARS Pharmaceuticals, Inc.. A complete text table follows the diagram.
Novel delivery systems and allergy therapeutics expand access to emergency and specialty care.
Swipe to explore
The operating total is tied to the downloaded filing; the destination is an editorial label for the disclosed business engine, with no invented segment allocation.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Reported operating total | 1 | $12M | Directly reported in the downloaded 10-Q |
| Allergy-treatment platform | 2 | $12M | Novel delivery systems and allergy therapeutics expand access to emergency and specialty care. |
| From | To | Value |
|---|---|---|
| Reported operating total | Allergy-treatment platform | $12M |